Surge in M&A Activity
Total M&A dollar volumes in Q3 2025 were 40.9% higher year-over-year compared to Q3 2024, benefiting Goldman Sachs BDC with the highest level of new investment commitments and repayments since 2022.
High Investment Commitments
New investment commitments reached approximately $470.6 million across 27 portfolio companies, marking the highest level since Q4 2021.
Strategic Investments
Notable investments included Shields Health Solutions, one of the largest specialty pharmacy operators in the U.S., and Newtek Merchant Solutions, showcasing GSBD's ability to secure significant roles in financing.
Repayment Activity
Increased repayment activity with $374.4 million for the quarter, 86% of which were from pre-2022 investments.
Strong Financial Position
Ending net debt-to-equity ratio of 1.17x, below the target leverage of 1.25x, with approximately $1.143 billion of borrowing capacity remaining under the revolving credit facility.